Wedmont Private Capital Bio Rad Laboratories, Inc. Transaction History

Wedmont Private Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	BUY	$418.69 - $503.0 $22,609 - $27,162	54 Added 8.26%	708 $339,000
Q4 2022 Jan 09, 2023	BUY	$351.71 - $456.01 $29,191 - $37,848	83 Added 14.54%	654 $0
Q3 2022 Oct 03, 2022	SELL	$412.59 - $563.26 $110,161 - $150,390	-267 Reduced 31.86%	571 $238,000
Q2 2022 Jul 11, 2022	BUY	$463.67 - $597.16 $388,555 - $500,420	838 New	838 $415,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

Stay updated on Wedmont Private Capital with notifications on news.